Inventor
Kim ASKEW
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C12YEnzymes22%
C12NMicroorganisms or enzymes17%
C07KPeptides11%
A01KAnimal husbandry6%
PatentTitleYear
12,564,645Methods for treatment of methylmalonic acidemia202612,268,754Composition and methods for treatment of ornithine transcarbamylase deficiency202512,134,790Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)202411,364,284Methods of treating myointimal proliferation2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to INOZYME PHARMA INC (2)· patent assignee history
2022Patents assigned to UNIV MUENSTER WESTFAELISCHE WILHELMS (1)· patent assignee history
2022–2026Based in US· patent location history
2025–2026Patents assigned to TRANSLATE BIO INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INOZYME PHARMA INC | 2 | 2022–2024 |
| TRANSLATE BIO INC | 2 | 2025–2026 |
| UNIV MUENSTER WESTFAELISCHE WILHELMS | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2026 |